Collegium Pharmaceutical, Inc. (COLL)
24.75
+0.54
(+2.23%)
USD |
NASDAQ |
Nov 09, 10:09
Collegium Pharmaceutical Total Assets (Quarterly) : 2.096B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.096B |
| June 30, 2026 | 2.136B |
| March 31, 2026 | 1.652B |
| December 31, 2025 | 1.686B |
| September 30, 2025 | 1.607B |
| June 30, 2025 | 1.593B |
| March 31, 2025 | 1.631B |
| December 31, 2024 | 1.664B |
| September 30, 2024 | 1.635B |
| June 30, 2024 | 1.053B |
| March 31, 2024 | 1.114B |
| December 31, 2023 | 1.143B |
| September 30, 2023 | 1.178B |
| June 30, 2023 | 1.214B |
| March 31, 2023 | 1.214B |
| December 31, 2022 | 1.174B |
| September 30, 2022 | 1.201B |
| June 30, 2022 | 1.246B |
| March 31, 2022 | 1.246B |
| December 31, 2021 | 692.08M |
| September 30, 2021 | 741.80M |
| June 30, 2021 | 713.74M |
| March 31, 2021 | 646.06M |
| December 31, 2020 | 643.84M |
| Date | Value |
|---|---|
| September 30, 2020 | 643.84M |
| June 30, 2020 | 646.87M |
| March 31, 2020 | 634.79M |
| December 31, 2019 | 306.30M |
| September 30, 2019 | 303.98M |
| June 30, 2019 | 301.58M |
| March 31, 2019 | 294.36M |
| December 31, 2018 | 291.24M |
| September 30, 2018 | 646.51M |
| June 30, 2018 | 673.33M |
| March 31, 2018 | 696.28M |
| December 31, 2017 | 135.57M |
| September 30, 2017 | 122.67M |
| June 30, 2017 | 124.52M |
| March 31, 2017 | 139.85M |
| December 31, 2016 | 162.02M |
| September 30, 2016 | 98.72M |
| June 30, 2016 | 119.72M |
| March 31, 2016 | 136.34M |
| December 31, 2015 | 97.72M |
| September 30, 2015 | 107.05M |
| June 30, 2015 | 114.17M |
| March 31, 2015 | 47.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.568B |
| Corcept Therapeutics, Inc. | 1.034B |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 197.42B |
| Eli Lilly & Co. | 148.07B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.799B |
| Shareholders Equity (Quarterly) | 296.44M |
| Debt to Equity Ratio | 4.074 |
| Current Ratio | 1.014 |
| Net Debt Paydown Yield | -7.55% |